Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

NCT04430517 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Mild Alzheimer Disease

Interventions

DRUG: Nicotinamide riboside

Sponsor

Mclean Hospital

Collaborators

[object Object]